Check 35,000+ stocks against 26 valuation models and 37 quality factors

ALLIANCE HEALTHCARE GROUP LTD (MIJ) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of ALLIANCE HEALTHCARE GROUP LTD S$0.38, price S$0.18, upside +111.1%, quality 63 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? Yes
Good quality? Yes
Add to watchlist

Healthcare · SG

AH Thin data Oct 3, 2026

ALLIANCE HEALTHCARE GROUP LTD

MIJ · SG

Clearly undervaluedStrong Fair Value upside, but quality is only moderate.

✓Fair value 0.3800 SGD · Strongly undervalued (+111.1%)

✓Quality 63/100

✓Healthy Growth (revenue 5y +13.5 %/yr)

!Thin margins · 4.1% net margin (TTM)

✓Low debt · generates free cash flow

✓2.8% dividend yield · Well covered

✓Ranks above peers (11/14)

!Narrow moat 35/100

!Evidence only low, so the estimate is less certain

26 models, one by oneBear 0.2900 SGD to bull 0.4800 SGD Growth analysisrevenue history, year by year Quality 63/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch ALLIANCE HEALTHCARE GROUP LTD for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.

How to read this chart

60‑month range 0.0900 SGD – 0.2100 SGD · fair‑value band 0.2900 SGD – 0.4800 SGD · the 0.1800 SGD price screens below the 0.3800 SGD fair value. Dashed = 300-day average. As of Oct 3, 2026.

Follow ALLIANCE HEALTHCARE GROUP in your weekly email

Every Wednesday you see whether ALLIANCE HEALTHCARE GROUP is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Alliance Healthcare Group Limited, an investment holding company, provides corporate health solutions in Singapore. The company operates through General Practitioner (GP) Clinic Services, Specialist Care Services, Managed Healthcare Solutions, Pharmaceutical Services, Mobile and Digital Health Services, and Others segments. It also offers managed healthcare solutions to corporations and insurance companies. In addition, the company provides medical services by specialists and general practitioners, and mobile and home care services. Further, it offers administrative and management services. Further, the company is involved in the wholesale of pharmaceutical products and services, including medicines and health supplements, and medical devices. Alliance Healthcare Group Limited was incorporated in 2006 and is headquartered in Singapore. The company is a subsidiary of Alpine Investment Holdings Pte. Ltd.

Stock analysis

ALLIANCE HEALTHCARE GROUP LTD (MIJ) currently trades at 0.1800 SGD, while our model-based Fair Value estimate is 0.3800 SGD, implying the stock looks roughly 52.6% undervalued today.

Valuation

Bull case: the Growth DCF group reads highest at a median of 0.9800 SGD per share, and 22 of the 26 models we run sit above the 0.1800 SGD price.

Bear case: the Asset-Based group reads lowest at 0.0900 SGD, and 4 of the 26 models stay below the price. Evidence for this calculation is low.

Scenario range: 0.2900 SGD (bear) to 0.4800 SGD (bull), the price of 0.1800 SGD sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 63/100 (solid quality), in the Healthcare sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

ALLIANCE HEALTHCARE GROUP LTD reported revenue of 87.4M SGD in FY2026 versus 54.8M SGD in FY2022, a compound +12.4%/yr. Reported net income was 3.6M SGD in FY2026, compounding +3.8%/yr from FY2022.

Key figures

Market cap 37.2M SGD (≈ $29.1M) · P/E ratio 9.0 · P/S ratio 0.37 · EPS (TTM) 0.0200 SGD · Dividend yield 2.8% · Net margin 4.1% · Return on equity 13.4% · Return on assets (EBIT) 10.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).

What moves the price

The share trades about 14% below its 52-week high and 100% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at 111%, MIJ screens cheaper than that median.

Fair Value models

Bear 0.2900 SGD Fair Value 0.3800 SGD Bull 0.4800 SGD

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 3 months old). Earnings retained since then (0.0039 SGD per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

FCF DCF 0.6200 SGD 1.08 SGD 1.87 SGD 78

Growth DCF 0.6100 SGD 1.02 SGD 1.68 SGD 76

Residual Income 0.1200 SGD 0.1500 SGD 0.2300 SGD 75

All 26 models by family

DCF Models

FCF DCF 0.6200 SGD 1.08 SGD 1.87 SGD 78

Owner Earnings 0.5200 SGD 0.8900 SGD 1.53 SGD 74

5Y Revenue Exit 0.5900 SGD 0.9900 SGD 1.56 SGD 71

5Y EBITDA Exit 0.7800 SGD 1.40 SGD 2.19 SGD 73

5Y P/E Exit 0.4400 SGD 0.6700 SGD 0.9400 SGD 71

10Y Revenue Exit 0.5800 SGD 0.9700 SGD 1.58 SGD 65

10Y EBITDA Exit 0.7200 SGD 1.26 SGD 2.12 SGD 66

10Y P/E Exit 0.4900 SGD 0.7300 SGD 1.07 SGD 63

Earnings-Based

Graham-Dodd 0.1200 SGD 0.6000 SGD 0.8300 SGD 64

Lynch FV 0.1600 SGD 0.2300 SGD 0.3000 SGD 61

PEG = 1.0 0.1600 SGD 0.2300 SGD 0.3000 SGD 57

EPV 0.5200 SGD 0.6000 SGD 0.6600 SGD 74

Dividend Discount

Gordon GGM 0.0100 SGD 0.0200 SGD 0.0300 SGD 67

DDM Multi-Stage 0.0100 SGD 0.0200 SGD 0.0200 SGD 67

Multiples

P/E Multiple 0.2900 SGD 0.3800 SGD 0.4800 SGD 63

P/S Multiple 0.2200 SGD 0.3000 SGD 0.3700 SGD 58

P/B Multiple 0.2200 SGD 0.3000 SGD 0.3700 SGD 55

EV/EBIT 0.7700 SGD 1.01 SGD 1.24 SGD 66

EV/EBITDA 0.9100 SGD 1.19 SGD 1.47 SGD 67

EV/Revenue 0.5700 SGD 0.7900 SGD 1.00 SGD 54

Asset-Based

NCAV (Graham) 0.0700 SGD 0.0900 SGD 0.1300 SGD 54

Growth DCF

Growth DCF 0.6100 SGD 1.02 SGD 1.68 SGD 76

Rev-Margin DCF 0.5900 SGD 0.9800 SGD 1.51 SGD 71

Economic Profit

Residual Income 0.1200 SGD 0.1500 SGD 0.2300 SGD 75

ROIC Compounder 0.5500 SGD 0.6600 SGD 0.7700 SGD 72

Growth Earnings

Growth-Adj P/E 0.2500 SGD 0.3600 SGD 0.4700 SGD 67

Open the full fair value analysis →

Notify me when MIJ reaches fair value

Put MIJ on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 63/100

Of which business quality 65 · Market factors (momentum, volatility) 67

Profitability 55

Margins and returns on capital today

Quality Growth 67

Are margins and returns improving?

Cashflow 68

Earnings quality: real cash, not paper profit

Fin. Strength 61

Balance sheet, leverage, solvency risk

Investment 61

Disciplined investing over empire-building

Low Volatility 50

Calm price path (market factor)

Momentum 74

Price trend over the last 3–12 months (market factor)

52W Momentum 75

Distance to the 52-week high (market factor)

Net Issuance 80

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 94/100

Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Revenue growth 1 year

+13.3%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+14.6%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+13.5%

Start year 2021 (pandemic)

Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+13.3%

’19

’20

’21

’22

’23

’24

’25

’26

What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.

+6.6%

Earnings growth per share plus dividend.

Earnings per share, growth per year+3.8%

Dividend (yield on the price)2.8%

2026 sits 137% above its own trend. The rate follows the median trend of the last 5 years, not that single year.

Growth Forecast

Little optimism in the price

The price assumes less growth than the company has delivered so far.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

−25.6%

Yearly growth needed for the next five years to justify today's price.

What forecasts expect

n/a

No analyst forecast available.

After inflation (Singapore: IMF forecast 2.0% a year to 2030, 1.7% from 2016 to 2025) that is about −27.0% a year for the price.

Watch MIJ, get fair value alerts →

Compare ALLIANCE HEALTHCARE GROUP LTD with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 246 stocks

Beats the industry median on 9/14 measures

Overall it ranks above its industry peers.

Valuation

Quality Score 59 · Above median

Fair Value upside −11.1% · Below median

Profitability

Return on equity (TTM) 9.7% · Above median

Return on assets 2.2% · Below median

Net margin (TTM) 3.4% · Below median

Operating margin (TTM) 4.8% · Below median

Growth and dividend

Revenue growth 11.6% · Above median

Dividend yield (TTM) 2.8% · Above median

Balance sheet

Debt / equity 0.27× · Above median

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/E (TTM) 9.0× · Cheapest 25%

P/B 1.52× · Cheaper than median

P/S (TTM) 0.46× · Cheapest 25%

P/FCF 9.0× · Cheaper than median

EV/EBITDA 5.5× · Cheapest 25%

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)100 · sector 34

FUTURE (revenue growth)75 · sector 26

PAST (return on equity)54 · sector 31

HEALTH (low debt)91 · sector 90

DIVIDEND (yield)56 · sector 39

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
HCA Healthcare, Inc HCA	$431.63	$597.97	+39%
Fresenius SE FRE	€43.64	€34.49	−21%
Dr. Sulaiman Al Habib Medical Services Group 4013	225.00 SAR	109.45 SAR	−51%
Tenet Healthcare Corporation THC	$257.93	$274.35	+6%
IHH Healthcare Berhad, an investment holding company, 5225	8.03 MYR	4.87 MYR	−39%
Apollo Hospitals Enterprise Limited APOLLOHOSP	₹8,889	₹2,908	−67%
Encompass Health Corporation EHC	$123.47	$94.47	−23%
Fresenius Medical Care AG FMS	$22.27	$45.84	+106%
DaVita Inc DVA	$178.07	$215.81	+21%
Aier Eye Hospital Group 300015	¥7.91	¥10.86	+37%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

ALLIANCE HEALTHCARE GROUP LTD · Fair Value
0.3800 SGD +53%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/MIJ" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">ALLIANCE HEALTHCARE GROUP LTD · Fair Value</span><br><b style="font-size:20px">0.3800 SGD</b> <span style="color:var(--fvc-g-mitte);font-weight:700;font-size:14px">+53%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "ALLIANCE HEALTHCARE GROUP LTD Fair Value". https://www.fairvalue-calculator.com/stock/MIJ

Frequently asked questions

Is ALLIANCE HEALTHCARE GROUP LTD (MIJ) overvalued or undervalued?

As of Oct 3, 2026, our model estimates a fair value of 0.3800 SGD versus a price of 0.1800 SGD, about +111% upside (undervalued).

What is the fair value of MIJ?

Our model-based fair value for ALLIANCE HEALTHCARE GROUP LTD is 0.3800 SGD (as of Oct 3, 2026), built from audited fundamentals. The current price: 0.1800 SGD.

What is the quality score of MIJ?

ALLIANCE HEALTHCARE GROUP LTD has a Quality Score of 63/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

Our model-based price target is the fair value of 0.3800 SGD (as of Oct 3, 2026) from 26 valuation models. Cautious scenario 0.2900 SGD, optimistic scenario 0.4800 SGD. It is a calculation from audited fundamentals, not an analyst target.

What is the ALLIANCE HEALTHCARE GROUP LTD stock forecast for 2026?

Our models put fair value at 0.3800 SGD, about +111% upside versus a price of 0.1800 SGD (undervalued). Cautious scenario 0.2900 SGD, optimistic scenario 0.4800 SGD. The calculation is refreshed regularly with new filings.

What is the revenue of ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

ALLIANCE HEALTHCARE GROUP LTD reported trailing-twelve-month revenue of about 87.4M SGD (latest available figure, as of Oct 3, 2026).

Does ALLIANCE HEALTHCARE GROUP LTD pay a dividend?

ALLIANCE HEALTHCARE GROUP LTD currently shows a dividend yield of about 2.78% relative to its recent price (as of Oct 3, 2026).

What growth is priced into ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

For today's price to be fair in a discounted-cash-flow model, ALLIANCE HEALTHCARE GROUP LTD would have to grow free cash flow by -25.6 % per year for five years (discount rate 8.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +13.5 % per year. As of Oct 3, 2026.

What discount rate (WACC) does the fair value of MIJ use?

Our models discount ALLIANCE HEALTHCARE GROUP LTD at 8.3 %: a base by market capitalisation (nano), damped by beta 0.05, country premium for Singapore. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For ALLIANCE HEALTHCARE GROUP LTD that is -25.6 % per year a year over ten years, using the same discount rate (8.3 %) and the same formula as our fair value.

How much growth has ALLIANCE HEALTHCARE GROUP LTD (MIJ) delivered so far?

Over the past 5 years revenue at ALLIANCE HEALTHCARE GROUP LTD grew +13.5 % a year. The price currently implies -25.6 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of ALLIANCE HEALTHCARE GROUP LTD (MIJ) growing?

The median revenue growth in the sector is +5.1 % a year. That is the yardstick for the growth priced into ALLIANCE HEALTHCARE GROUP LTD (-25.6 % per year a year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

The free-cash-flow yield on the price is 22.36 %: that much free cash flow ALLIANCE HEALTHCARE GROUP LTD produces per unit of market value. When it exceeds the discount rate of our models (8.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For ALLIANCE HEALTHCARE GROUP LTD it is 0.3800 SGD per share (as of Oct 3, 2026), against a price of 0.1800 SGD. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).

Is ALLIANCE HEALTHCARE GROUP LTD stock overvalued or undervalued in 2026?

As of Oct 3, 2026, MIJ trades below its calculated fair value: price 0.1800 SGD, fair value 0.3800 SGD, a gap of about +111% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of MIJ?

No. The price is what the market pays today (0.1800 SGD); the fair value is what the company's own numbers justify (0.3800 SGD). For ALLIANCE HEALTHCARE GROUP LTD the two are 0.2000 SGD per share apart. That gap is exactly why we show both numbers side by side.

How much is ALLIANCE HEALTHCARE GROUP LTD worth?

The market values ALLIANCE HEALTHCARE GROUP LTD at about 37.2M SGD (market capitalisation, as of Oct 3, 2026). Per share that is 0.1800 SGD; our models calculate a fair value of 0.3800 SGD per share.

What do the bullish and bearish scenarios say about MIJ?

Our models span a range for ALLIANCE HEALTHCARE GROUP LTD: cautious scenario 0.2900 SGD, base 0.3800 SGD, optimistic 0.4800 SGD per share (as of Oct 3, 2026, price 0.1800 SGD). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of MIJ?

ALLIANCE HEALTHCARE GROUP LTD trades at a price-to-earnings ratio of 9.0 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 0.3800 SGD is built from several models across several years. Other multiples: P/B 1.5, P/S 0.5, EV/EBITDA 5.5.

How solid is the balance sheet of ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

Balance-sheet figures for ALLIANCE HEALTHCARE GROUP LTD (as of Oct 3, 2026): return on equity 9.7%, debt of 0.27 per unit of equity. They feed the Quality Score of 63/100, which measures business quality independently of the share price.

How far is MIJ from its 52-week high?

ALLIANCE HEALTHCARE GROUP LTD trades at 0.1800 SGD, about 14% below its 52-week high of 0.2100 SGD and 100% above the low of 0.0900 SGD (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of 0.3800 SGD is for.

Which stocks are comparable to ALLIANCE HEALTHCARE GROUP LTD?

From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, Tenet Healthcare Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is ALLIANCE HEALTHCARE GROUP LTD stock attractive at the current price?

The data as of Oct 3, 2026: price 0.1800 SGD, calculated fair value 0.3800 SGD (+111%), Quality Score 63/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of MIJ calculated?

We run ALLIANCE HEALTHCARE GROUP LTD through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.3800 SGD, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 14.5 % above its aggregate fair value. ALLIANCE HEALTHCARE GROUP LTD currently trades 53 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

The closing price on Oct 2, 2026 was 0.1800 SGD. Our model-based fair value is 0.3800 SGD, about +111% upside (undervalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with ALLIANCE HEALTHCARE GROUP LTD right now?

The price is below even our cautious bear case (0.2900 SGD). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (63/100) at a price below fair value, the discount is the argument here, not the business quality.

Key figures of ALLIANCE HEALTHCARE GROUP LTD

How large is the market capitalisation of ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

The market capitalisation of ALLIANCE HEALTHCARE GROUP LTD is 37.2M SGD (≈ $29.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

The price-to-sales ratio of ALLIANCE HEALTHCARE GROUP LTD is 0.37 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

Earnings per share at ALLIANCE HEALTHCARE GROUP LTD are 0.0200 SGD (price ÷ EPS = P/E 9.0). Earnings per share over the last twelve months: total profit spread across every single share.

What is the dividend yield of ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

The dividend yield of ALLIANCE HEALTHCARE GROUP LTD is 2.8% (payout 25.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.

What is the net margin of ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

The net margin of ALLIANCE HEALTHCARE GROUP LTD is 4.1% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

The return on equity (ROE) of ALLIANCE HEALTHCARE GROUP LTD is 13.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

On an EBIT basis the return on assets of ALLIANCE HEALTHCARE GROUP LTD is 10.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

The operating margin of ALLIANCE HEALTHCARE GROUP LTD is 5.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

Revenue at ALLIANCE HEALTHCARE GROUP LTD is growing +14.9% versus a year earlier (3y avg +14.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at ALLIANCE HEALTHCARE GROUP LTD (MIJ)?

Earnings per share at ALLIANCE HEALTHCARE GROUP LTD are growing +68.8% versus a year earlier. How much earnings per share grew versus a year earlier.

Free · no account needed

Watch ALLIANCE HEALTHCARE GROUP LTD in the live analysis

One click puts ALLIANCE HEALTHCARE GROUP LTD on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.